BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,597 | -12.9% | 6,322 | +5.2% | 0.01% | -14.3% |
| Q2 2023 | $273,781 | +21.5% | 6,009 | +8.2% | 0.01% | +7.7% |
| Q1 2023 | $225,356 | -18.7% | 5,556 | +2.2% | 0.01% | -23.5% |
| Q4 2022 | $277,214 | -16.8% | 5,439 | -12.1% | 0.02% | -32.0% |
| Q3 2022 | $333,000 | +3.4% | 6,189 | +23.6% | 0.02% | -10.7% |
| Q2 2022 | $322,000 | -26.5% | 5,008 | -11.4% | 0.03% | -15.2% |
| Q1 2022 | $438,000 | -9.7% | 5,653 | +0.1% | 0.03% | -8.3% |
| Q4 2021 | $485,000 | +4.1% | 5,648 | -2.6% | 0.04% | -5.3% |
| Q3 2021 | $466,000 | -10.6% | 5,796 | -10.4% | 0.04% | +15.2% |
| Q2 2021 | $521,000 | -4.2% | 6,472 | +0.3% | 0.03% | -15.4% |
| Q1 2021 | $544,000 | -3.2% | 6,455 | -7.8% | 0.04% | -17.0% |
| Q4 2020 | $562,000 | +66.3% | 7,000 | +66.8% | 0.05% | +38.2% |
| Q3 2020 | $338,000 | +0.6% | 4,197 | +7.7% | 0.03% | -26.1% |
| Q2 2020 | $336,000 | +2.4% | 3,897 | -3.4% | 0.05% | -2.1% |
| Q1 2020 | $328,000 | -2.1% | 4,035 | +0.6% | 0.05% | +17.5% |
| Q4 2019 | $335,000 | +5.3% | 4,009 | +10.2% | 0.04% | -7.0% |
| Q3 2019 | $318,000 | +25.7% | 3,639 | -5.4% | 0.04% | -12.2% |
| Q4 2018 | $253,000 | -13.7% | 3,847 | +1.2% | 0.05% | -22.2% |
| Q3 2018 | $293,000 | +3.5% | 3,800 | -0.7% | 0.06% | -12.5% |
| Q2 2018 | $283,000 | +81.4% | 3,827 | +55.4% | 0.07% | +71.4% |
| Q1 2018 | $156,000 | +57.6% | 2,462 | +71.9% | 0.04% | +61.5% |
| Q4 2017 | $99,000 | +52.3% | 1,432 | +34.5% | 0.03% | -7.1% |
| Q3 2017 | $65,000 | +400.0% | 1,065 | 0.0% | 0.03% | +366.7% |
| Q2 2017 | $13,000 | -78.0% | 1,065 | -5.9% | 0.01% | -84.6% |
| Q1 2017 | $59,000 | +78.8% | 1,132 | +54.6% | 0.04% | +56.0% |
| Q4 2016 | $33,000 | – | 732 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |